SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant bearish pressure as investors express frustration over a lack of new enterprise contract catalysts and ongoing concerns regarding cash burn and dilution. Despite community debates over the company's long-term potential in voice and Agentic AI, heavy short interest remains a primary focal point, leaving traders divided between those accumulating at lower price levels and others concerned about the stock's persistent lack of upward momentum.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the market digests strong June delivery figures alongside aggressive growth in its premium SUV segment, despite persistent concerns over guidance accuracy and sector-wide volatility. Investors are actively debating the company's long-term profitability and the impact of the ongoing competition with rivals like Li Auto and Xpeng within a saturated Chinese EV landscape.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing significant volatility following earnings results that beat revenue and profit expectations, though investors remain cautious due to guidance on ongoing demand softness in key international markets. The community is sharply divided between those viewing the current valuation as a generational buying opportunity and others skeptical of a turnaround amid intense competitive and macroeconomic pressures.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is seeing renewed investor interest as the software sector undergoes a rotation, fueled by insider buying, strong institutional block orders, and a shifting narrative that enterprise AI will complement rather than disrupt existing platforms. The community is actively discussing a potential rebound as the stock shows technical strength, with many focusing on the upcoming quarterly results and the company's role as a key orchestrator in enterprise AI.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is surging as investors react to a milestone earnings report that showcased the company's first quarterly profit and significant revenue growth. The community is buzzing over the stock's potential for a short squeeze, fueled by high short interest and anticipation surrounding a major upcoming court verdict against Google.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is experiencing significant volatility driven by its transition from the Russell 2000 to the Russell 200 index, prompting mechanical rebalancing and institutional selling. Despite the short-term pressure, the community remains intensely focused on the company's long-term potential as a critical power infrastructure provider for AI data centers, fueled by its expanded $25 billion financing partnership with Brookfield.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is currently trending as investors monitor progress toward the company's July criticality deadline at its Groves isotope reactor, following recent Department of Energy safety approvals. The community is actively debating the stock's long-term potential as a critical infrastructure play for AI power demands, despite ongoing discussions regarding share dilution and the company's pre-revenue status.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is seeing significant retail and institutional interest fueled by speculation surrounding a potential buyout, underscored by recent corporate governance changes and the highly anticipated 80th clinical event for its REGAL trial. While community sentiment remains intensely polarized between optimistic long-term bulls anticipating a paradigm shift in cancer treatment and vocal bears questioning trial timelines and clinical endpoints, the discussion is dominated by the strategic positioning of large-scale capital and the implications of the ongoing data monitoring committee's oversight.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is experiencing significant downward pressure and volatility as investors weigh the potential long-term benefits of stablecoin adoption against intensifying competitive threats from newly announced industry consortia. While some in the community see the current price action as an overreaction that offers a long-term entry point, others are closely monitoring insider selling patterns and the status of regulatory catalysts like the Clarity Act for signs of a turnaround.

General Mills, Inc. engages in the manufacture of food. Its portfolio of brands includes household names like Cheerios, Nature Valley, Blue Buffalo, Häagen-Dazs, Old El Paso, Pillsbury, Betty Crocker, Totino’s, Annie’s, Wanchai Ferry and more. It operates through the following segments: North America Retail, International, North America Pet, and North America Foodservice. The North America Retail segment includes grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, convenience stores, and e-commerce grocery providers. The International segment refers to the retail and foodservice businesses outside of the US and Canada. The North America Pet segment includes pet food products sold in national pet superstore chains, e-commerce retailers, grocery stores, regional pet store chains, mass merchandisers, and veterinary clinics and hospitals. The North America Foodservice segment offers ready-to-eat cereals, snacks, refrigerated yogurt, frozen meals, unbaked and fully baked frozen dough products, baking mixes, and bakery flour. The company was founded by Cadwallader C. Washburn on June 20, 1928 and is headquartered in Minneapolis, MN.

General Mills, Inc.

General Mills is trending as investors weigh an updated fiscal outlook featuring aggressive cost-cutting targets against broader consumer demand headwinds. The community is actively debating the stock's value as a defensive, high-yield dividend play amidst institutional rotation and ongoing productivity initiatives aimed at restoring long-term growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease

Roche won FDA priority review for Enspryng in thyroid eye disease, with a decision date in October and phase III data backing the filing.

Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value

Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value...

Nurix Stock Up 29% in a Month: Here's What You Should Know

NRIX rallies on its collaboration with Roche for bexobrutideg, featuring a $700 million upfront payment and potential milestone payouts of up to $2.3 billion.

Nurix Therapeutics (NRIX) Soars 16.4%: Is Further Upside Left in the Stock?

Nurix Therapeutics (NRIX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Canopy Growth Corporation (CGC) Reports Q4 Loss, Lags Revenue Estimates

Canopy Growth (CGC) delivered earnings and revenue surprises of -199.82% and -2.47%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

TG Therapeutics (TGTX) Soars 7.5%: Is Further Upside Left in the Stock?

TG Therapeutics (TGTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Strength Seen in Nurix Therapeutics (NRIX): Can Its 6.8% Jump Turn into More Strength?

Nurix Therapeutics (NRIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Company News for Jun 9, 2026

Companies In The News Are: CPB, FCEL, NRIX, WIX.

Roche, Nurix Team Up to Advance BTK Degrader Bexobrutideg

Roche collaborates with Nurix on bexobrutideg, a BTK degrader for blood cancers, while expanding potential use into immunology and neurology.

FDA Milestones Fueling Expansion

The biotechnology sector delivered several notable developments. $TNGX, $NTHI, $AIM, $AZN, $NRIX, $NYXH

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.

Nurix Therapeutics Inc

NRIX Stock Surges Nearly 70% Premarket Today – Roche And Nurix’s Blood Cancer Drug Collaboration Can Tap A $41B Market

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$24.26
Prev Close	$23.85
Open	$23.94
Dividend Yield	0.00%
50-Day Moving Average	$17.23
Beta	1.62
Avg. Volume	1.06M
PE Ratio	-7.68

52-Week High	$24.88
52-Week Low	$8.20
Market Capitalization	$2.51B
EPS (Annual)	-$3.05
Price to Book	5.22
Revenue Per Employee	$264,921.14

Feed

News

Sentiment

Earnings

Fundamentals

Info

NRIXNurix Therapeutics Inc

Latest NRIX News